Dr. Smith's ECG Blog
  • About
  • Resources
  • Lectures + Podcasts
  • Rules + Equations

Thursday, September 11, 2014

Intravenous Nitroglycerine in STEMI, with data: Avoid its use if giving tPA

If you are giving tPA to patients with STEMI, it is wise to avoid IV nitroglycerine.  I am revisiting this topic because of a recent case I posted in which a patient who was on IV nitro received tPA.  This patient was very hypertensive, and thus needed something to control BP. But I would advise against nitroglycerine.

This is data that very few cardiologists are aware of

Background: 

First, know that, in the reperfusion era, there is absolutely no data to support the use of nitroglycerine in STEMI.  See the ACC/AHA recommendation below that puts the level of evidence at “C”.  I have pasted below the ACC/AHA guideline.  There are a total of 4 references provided.   Three are from the pre-reperfusion era (1 shows is a pooled analysis showing decrease in mortality from 7.7% to 7.4%); 1 uses transdermal nitrates.

There is data showing worse outcome with nitroglycerine when tPA is used (see 3 abstracts pasted below, one is a randomized human study, though small).  This data is far better than that referenced in the guidelines, and actually also includes rationale and lab confirmation (tPA levels are much lower with, than without, nitro drips).

The reason for this is that Nitro apparently increases hepatic blood flow and tPA metabolism, lowering tPA blood levels.

Some have argued that GISSI-3 proved nitro to be efficacious.  This simply shows a bias towards nitro and away from any data about it.  GISSI-3 studied transdermal nitrates, given all day for 6 weeks.  Furthermore, and I quote from the article: “the systematic administration of transdermal GTN did not show any independent effect on the outcome measures (0.94 [0.84-1.05] and 0.94 [0.87-1.02]).”

The application of literature that is prior to the thrombolytic and even aspirin era to the reperfusion era of today is not rational. 

With the evidence below, and at least one other study (White CM.  Pharmacotherapy 20(4):380-2, April 2000) confirming decrease in tPA levels with use of nitro, it would be very unwise to give nitrates and expect tPA to work.

Even with HTN or pulmonary edema, I would use another drug if I were giving tPA and expecting reperfusion.  Exactly which medication would be better, however, is uncertain.  Beta blockers probably do not have this effect on tPA, but some other vasodilators (if beta blockade does not sufficiently lower the BP) might also have this effect.  IV enalapril is one possibility, but can have irreversible hypotensive effects.  Nitroprusside is great to lower BP, but does it also lower tPA levels?  In any case, I would try beta blockade first if there are no absolute contraindications.  The BP must be less than 185/110 in order to give tPA and avoid catastrophic intracranial bleeding.

Finally, the dose used that interrupted reperfusion was high (100 mcg/min), but any efficacious dose of nitro would have to be high (many physicians forget that sublingual nitro q 5 minutes is equal to 80 mcg/min).

tPA and Nitroglycerine: an Annotated Bibliography:

Concurrent nitroglycerine therapy impairs tissue-type plasminogen activator-induced thrombolysis in patients with acute myocardial infarction.1

Nitroglycerin given with tissue-type plasminogen activator (t-PA) has been shown to decrease the thrombolytic effect of t-PA in animal models of coronary artery thrombosis. The present study was conducted to determine whether such an interaction between nitroglycerin and t-PA occurs in patients with acute myocardial infarction undergoing thrombolytic treatment. Patients with acute myocardial infarction were treated with t-PA plus saline solution (group 1; n = 11) or t-PA plus nitroglycerin (group 2; n = 36). Stable coronary artery reperfusion assessed by continuous ST-segment monitoring in 2 electrocardiographic leads, and release of creatine kinase occurred in 91% of group 1 patients and in 44% of group 2 patients (95% confidence interval, 14% to 82%; p < 0.02). Plasma levels of t-PA antigen were consistently (p < 0.005) higher in group 1 than in group 2 patients up to 6 hours after t-PA infusion. Conversely, plasminogen activator inhibitor-1 (PAI-1) levels were slightly higher in group 2 than in group 1 patients. These observations indicate that nitroglycerin given with t-PA significantly decreases the plasma t-PA antigen concentrations and impairs the thrombolytic effect of t-PA in patients with acute myocardial infarction.

Concurrent nitroglycerine administration decreases thrombolytic potential of tissue-type plasminogen activator.2

Dynamic coronary vasoconstriction may play a role in coronary artery reocclusion after successful thrombolysis. The effect of nitroglycerin on the thrombolytic effects of recombinant tissue-type plasminogen activator (rt-PA) was examined in dogs with an electrically induced occlusive coronary artery thrombus. Eleven dogs were randomly given rt-PA alone and seven rt-PA with nitroglycerin. The dose of rt-PA was 0.75 mg/kg body weight given over 20 min and the dose of nitroglycerin was 125 micrograms/min for 40 min. The reperfusion rate in the dogs given rt-PA alone was 73% (8 of 11 dogs) and that in the rt-PA plus nitroglycerin group was 57% (four of seven dogs) (p = NS). The time to thrombolysis (or reperfusion) in dogs receiving rt-PA plus nitroglycerin was 70% greater than in those receiving rt-PA alone (means +/- SD/29.8 +/- 9.9 versus 17.6 +/- 5.9 min, p less than 0.02), and the duration of reperfusion much shorter (11 +/- 17 versus 42 +/- 16 min, p less than 0.02). Peak coronary blood flow after reperfusion in dogs receiving rt-PA plus nitroglycerin was also less than in those receiving rt-PA alone (36 +/- 52 versus 63 +/- 20 ml/min, p less than 0.02). Reocclusion occurred in all dogs given rt-PA with nitroglycerin and in six of eight given rt-PA alone (p = NS). Plasma concentrations of rt-PA were lower when nitroglycerin was given with rt-PA alone (427 +/- 279 versus 1,471 +/- 600 ng/ml, p less than 0.01).  In addition, whole blood platelet aggregation decreased significantly with administration of rt-PA alone, but not with administration of rt-PA with nitroglycerin (0.23 ± 0.57 and 5.26 ± 6.23, respectively, p less than 0.02). Peripheral blood platelet count decreased during thrombus formation in all dogs; with administration of rt-PA alone, platelet counts stabilized but continued to decrease with concurrent administration of nitroglycerin with rt-PA (mean platelet counts at the end of rt-PA infusion 7.23 ± 1.68 and 4.78 ± 3.00 × 108/ml, respectively, p less than 0.02), suggesting continued sequestration of platelets in the intracoronary thrombus. In four additional dogs nitroglycerin was given after rt-PA-induced thrombolysis, but nitroglycerin failed to sustain coronary artery reperfusion.This study shows that 1) nitroglycerin given concurrently with rt-PA may have a detrimental effect on the thrombolytic potential of rt-PA, probably because of the reduction in plasma t-PA concentrations, and 2) nitroglycerin given after rt-PA-induced thrombolysis does not prevent coronary artery reocclusion.

Concurrent nitroglycerin administration reduces the efficacy of recombinant tissue-type plasminogen activator in patients with acute anterior wall myocardial infarction.3
The aim of this study was to evaluate the impact of concurrent nitroglycerin administration on the thrombolytic efficacy of recombinant tissue-type plasminogen activator (rTPA) in patients with acute anterior myocardial infarction (AMI). Sixty patients (53 men, 7 women; mean age 54 +/- 7 years) with AMI entered the study. Thirty-three patients were randomized to receive rTPA alone (100 mg in 3 hours) (group A) and 27 to receive rTPA plus nitroglycerin (100 micrograms/min) (group B). Time from the onset of chest pain and delivery of rTPA was similar in the two groups of patients. Patients in group A had signs of reperfusion more often than the patients in group B (25 of 33 or 75.7% vs 15 of 27 or 55.5%, p less than 0.05). Time to reperfusion was also shorter in group A than in group B (19.6 +/- 9.4 minutes vs 37.8 +/- 5.9 minutes, p less than 0.05). Group B had a greater incidence of in-hospital adverse events (9 of 27 vs 5 of 33, p less than 0.05) and a higher incidence of coronary artery reocclusion (8 of 15 or 53.3% vs 6 of 25 or 24%, p less than 0.05). Peak plasma levels of rTPA antigen were higher in group A compared with group B (1427 +/- 679 vs 512 +/- 312 ng/ml, p less than 0.01). In conclusion, concurrent nitroglycerin administration reduces the thrombolytic efficacy of rTPA in patients with AMI probably by lowering the plasma levels of rTPA antigen. The diminished efficacy of rTPA is associated with an adverse outcome.

References

1.         Nicolini FA, Ferrini D, Ottani F, et al. Concurrent nitroglycerine therapy impairs tissue-type plasminogen activator-induced thrombolysis in patients with acute myocardial infarction. Am J Cardiol 1994; 74:662-666.

2.         Mehta JL, Nicolini FA, Nichols WW, Saldeen TG. Concurrent nitroglycerine administration decreases thrombolytic potential of tissue-type plasminogen activator. J Am Coll Cardiol 1991; 17:805-811.  Full text: http://content.onlinejacc.org/article.aspx?articleID=1117488

3.         Romeo F, Rosano GM, Martuscelli E, et al. Concurrent nitroglycerin administration reduces the efficacy of recombinant tissue-type plasminogen activator in patients with acute anterior wall myocardial infarction. Am Heart J 1995; 130:692-697.





From ACC/AHA Guidelines
Class I
1. Patients with ongoing ischemic discomfort should receive sublingual nitroglycerin (0.4 mg) every 5  minutes for a total of 3 doses, after which an assessment should be made about the need for intravenous nitroglycerin.
(Level of Evidence: C)
2. Intravenous nitroglycerin is indicated for relief of ongoing ischemic discomfort, control of hypertension, or management of pulmonary congestion. (Level of
Evidence: C)
Class III
1. Nitrates should not be administered to patients with systolic blood pressure less than 90 mm Hg or greater than or equal to 30 mm Hg below baseline, severe bradycardia (less than 50 beats per minute [bpm]), tachycardia (more than 100 bpm), or suspected RV infarction. (Level of Evidence: C)
2. Nitrates should not be administered to patients who have received a phosphodiesterase inhibitor for erectile dysfunction within the last 24 hours (48 hours for tadalafil). (Level of Evidence: B)

The physiological effects of nitrates include reducing preload and afterload through peripheral arterial and venous
dilation, relaxation of epicardial coronary arteries to improve coronary flow, and dilation of collateral vessels, potentially creating a more favorable subendocardial to epicardial flow ratio (252-254). Vasodilation of the coronary arteries, especially at or adjacent to sites of recent plaque disruption, may be particularly beneficial for the patient with acute infarction. Nitrate-induced vasodilatation may also have particular utility in those rare patients with coronary spasm presenting as STEMI.

Clinical trial results have suggested only a modest benefit from nitroglycerin used acutely in STEMI and continued
subsequently. A pooled analysis of more than 80 000 patients treated with nitrate-like preparations intravenously or orally in 22 trials revealed a mortality rate of 7.7% in the control group, which was reduced to 7.4% in the nitrate group. These data are consistent with a possible small treatment effect of nitrates on mortality such that 3 to 4 fewer deaths would occur for every 1000 patients treated (152). Nitroglycerin may be administered to relieve ischemic pain and is clearly indicated as a vasodilator in patients with STEMI associated with LV failure. Nitrates in all forms should be avoided in patients with initial systolic blood pressures less than 90 mm Hg or greater than or equal to 30 mm Hg below and treatment with aspirin, beta-blockers, and ACE inhibitors. Nevertheless, any patient with a risk from the intervention that exceeds their STEMI risk reduction will, on average, do better without that treatment. This group will generally include patients with a higher risk from the intervention or a lower absolute risk reduction (generally because f a low absolute STEMI risk). This issue may be particularly important for younger patients, who tend to have a lower absolute risk of mortality (245), and for the elderly, who tend to have a higher risk from interventions, particularly with respect to fibrinolytic therapy (246). Precise estimates of risks and benefits are useful because the low STEMI risk in younger patients is often accompanied by a lower risk of interventions. In contrast, in the elderly, the higher intervention risk is accompanied by a higher STEMI risk (and thus a larger absolute reduction in risk with the intervention) (247). The use of any risk assessment tool should not contribute to any delay in providing the time-sensitive assessment and treatment strategies that patients with STEMI require. Further research is necessary to determine how these tools may best contribute to optimizing patient outcomes.

152. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet1995;345:669-85.
252. Abrams J. Hemodynamic effects of nitroglycerin and long-acting nitrates. Am Heart J 1985;110:216-24. 253. Winbury MM. Redistribution of left ventricular blood flow produced by nitroglycerin: an example of integration of the macroand microcirculation. Circ  Res 1971;28(Suppl 1):140-7.
254. Gorman MW, Sparks HV. Nitroglycerin causes vasodilatation within ischaemic myocardium. Cardiovasc Res 1980;14:515-21.



Posted by Steve Smith at 2:18 PM
Email ThisBlogThis!Share to TwitterShare to FacebookShare to Pinterest
Labels: nitroglycerin, Thrombolytics
Reactions: 

5 comments:

  1. Ahmed Sayed AhmedSeptember 12, 2014 at 4:37 PM

    Is Nitroglycerin has the same effect on Streptokinase ?!!

    ReplyDelete
    Replies
    1. Steve SmithSeptember 13, 2014 at 8:33 AM

      I don't know of any data. Sorry.

      Delete
      Replies
        Reply
    2. CG BronsonOctober 9, 2014 at 11:50 PM

      Amazing

      Delete
      Replies
        Reply
    3. Reply
  2. Floyd MiracleOctober 3, 2017 at 5:20 PM

    What's your opinion on ntg in STEMI? Since there's no solid evidence the decrease in mortality is statistically significant, should we still give it? This is a frequently debated topic on social media.

    ReplyDelete
    Replies
    1. Steve SmithOctober 11, 2017 at 4:29 PM

      Floyd,
      There is no good evidence for risk or benefit (no randomized trials that I know of). I think it probably helps more than hurts and so I would give it as long as the BP can handle it.
      Steve

      Delete
      Replies
        Reply
    2. Reply
Add comment
Load more...

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

Recommended Resources

about Dr. Smith

Associate Editors (since 2018) are: Pendell Meyers, Ken Grauer.

Dr. Stephen W. Smith is a faculty physician in the Emergency Medicine Residency at Hennepin County Medical Center (HCMC) in Minneapolis, MN, and Professor of Emergency Medicine at the University of Minnesota.

[ view Dr. Smith's Google Scholar Profile ]

Dr. Smith Articles on ACS (ECG and/or Troponin)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Disclaimer

Cases come from all over the world. Patient identifiers have been redacted or patient consent has been obtained. The contents of this site have not been reviewed nor approved by Hennepin County Medical Center and any views or opinions expressed herein do not necessarily reflect the views or opinions of Hennepin County Medical Center.

As of March 10, 2018, I've decided to run ads here. All ad revenue will go to my ECG research projects. We need funding. Up until now, my wife and I have funded the PERFECT (Paced ECG Requiring Fast Emergent Coronary Therapy) study by making her the full time coordinator without pay.

Dr. Smith's Book

Recommended Resources

The most fascinating book in EM history.



I wrote the Acute Coronary Syndromes Section in this book (15 chapters, 130 pages). It is a gold mine of information and ECG examples.



This is a great book on EKGs by my mentor, K. Wang.



More basic books for the less advanced learner:





Comments not appropriate for general posting, or interesting ECGs, may be sent here (do this judiciously!)

Always send ECGs in the correct orientation, not sideways!!: dr.smiths.ecg.blog@gmail.com.



I highly recommend using this blog as an atlas or textbook. Use the "label" below the archive (below) to search for all kinds of ECG cases, with discussion.

Follow on Twitter @smithECGBlog

Follow @smithECGBlog

Total Pageviews

Sparkline

Search This Blog

Tweet this

Tweet

Followers

Subscribe To

Posts
Atom
Posts
Comments
Atom
Comments

Popular Posts

  • Five Primary Patterns of Ischemic ST depression, without ST elevation. Some are STEMI-equivalents.
    Here are some basic concepts before we get into the ECGs: STEMI and NonSTEMI are arbitrary terms that may confuse the clinician. "S...
  • "Shark Fin": A Deadly ECG Sign that you Must Know!
    This case and discussion is written by Sam Ghali ( @EM_RESUS ), with a few edits by Smith   Case A 75-year-old man collapses to t...
  • Anterior MI in paced rhythm, dismissed by cardiologist, patient died.
    This was shown to me by a very astute Hennepin paramedic. Although this comes from a Hennepin paramedic, the patient was not brought to ...
  • A 37 year old woman with Chest Pain
    I have put up one post with 10 similar cases here . Don't miss the comments at the bottom! I was sent this ECG with the following ...
  • Shoulder pain after lifting a heavy box
    Written by Pendell Meyers, edits by Steve Smith This will be too easy for most long-time readers, but if you are at that level, sit back...
  • ST-Elevation in aVR with diffuse ST-Depression: An ECG pattern that you must know and understand!
    This case comes from Sam Ghali    ( @EM_RESUS ).  A 60-year-old man calls 911 after experiencing sudden onset chest pain, palpitations, a...
  • A middle aged man with unwitnessed cardiac arrest
    Written by Pendell Meyers, with edits by Steve Smith Thanks to my attending Nic Thompson who superbly led this resuscitation We receive...
  • Bizarre T-wave Inversions in a Patient without Chest Pain
    This was sent by a recent ultrasound fellow, asking for my ECG diagnosis. He stated that it is "an acute change from previous" ...
  • Hyperacute T waves
    Below are several examples of hyperacute T waves . Click here for more great examples of hyperacute T-waves . Click here for cases of &...
  • A crashing patient with an abnormal ECG that you must recognize
    Written by Pendell Meyers, with edits from Steve Smith Let's consider this nearly pathognomonic ECG without the clinical context (be...

Blog Archive

  • ►  2019 (24)
    • ►  February (7)
    • ►  January (17)
  • ►  2018 (143)
    • ►  December (10)
    • ►  November (14)
    • ►  October (11)
    • ►  September (13)
    • ►  August (9)
    • ►  July (14)
    • ►  June (11)
    • ►  May (10)
    • ►  April (16)
    • ►  March (11)
    • ►  February (11)
    • ►  January (13)
  • ►  2017 (111)
    • ►  December (9)
    • ►  November (13)
    • ►  October (10)
    • ►  September (6)
    • ►  August (11)
    • ►  July (11)
    • ►  June (8)
    • ►  May (10)
    • ►  April (9)
    • ►  March (12)
    • ►  February (5)
    • ►  January (7)
  • ►  2016 (93)
    • ►  December (6)
    • ►  November (8)
    • ►  October (9)
    • ►  September (5)
    • ►  August (9)
    • ►  July (6)
    • ►  June (7)
    • ►  May (8)
    • ►  April (5)
    • ►  March (13)
    • ►  February (8)
    • ►  January (9)
  • ►  2015 (131)
    • ►  December (9)
    • ►  November (11)
    • ►  October (13)
    • ►  September (10)
    • ►  August (12)
    • ►  July (10)
    • ►  June (10)
    • ►  May (10)
    • ►  April (14)
    • ►  March (12)
    • ►  February (8)
    • ►  January (12)
  • ▼  2014 (123)
    • ►  December (13)
    • ►  November (12)
    • ►  October (9)
    • ▼  September (10)
      • A Mystery Rhythm, Explained by K. Wang's Ladder Di...
      • Diffuse ST Elevation. What do you think?
      • Prolonged (63 minutes) Ventricular Fibrillation, F...
      • Two (apparent wide complex) Rhythms in One Patient...
      • Massive Excessively Discordant Anterior ST Elevati...
      • Intravenous Nitroglycerine in STEMI, with data: Av...
      • Great Chart of Pediatric ECG Intervals: QRS, QTc, ...
      • A 50-something year old with typical chest pain
      • One Hour Lecture: Supraventricular Tachycardias (i...
      • Inferior ST Elevation. BP 250/140.
    • ►  August (10)
    • ►  July (10)
    • ►  June (7)
    • ►  May (11)
    • ►  April (12)
    • ►  March (11)
    • ►  February (6)
    • ►  January (12)
  • ►  2013 (112)
    • ►  December (13)
    • ►  November (8)
    • ►  October (9)
    • ►  September (8)
    • ►  August (12)
    • ►  July (8)
    • ►  June (15)
    • ►  May (10)
    • ►  April (8)
    • ►  March (10)
    • ►  February (4)
    • ►  January (7)
  • ►  2012 (79)
    • ►  December (5)
    • ►  November (6)
    • ►  October (7)
    • ►  September (5)
    • ►  August (8)
    • ►  July (5)
    • ►  June (6)
    • ►  May (8)
    • ►  April (9)
    • ►  March (8)
    • ►  February (5)
    • ►  January (7)
  • ►  2011 (96)
    • ►  December (6)
    • ►  November (7)
    • ►  October (8)
    • ►  September (9)
    • ►  August (8)
    • ►  July (4)
    • ►  June (11)
    • ►  May (9)
    • ►  April (13)
    • ►  March (6)
    • ►  February (9)
    • ►  January (6)
  • ►  2010 (48)
    • ►  December (10)
    • ►  November (6)
    • ►  October (5)
    • ►  September (1)
    • ►  August (4)
    • ►  July (4)
    • ►  June (2)
    • ►  May (2)
    • ►  April (2)
    • ►  March (3)
    • ►  February (1)
    • ►  January (8)
  • ►  2009 (22)
    • ►  December (2)
    • ►  November (2)
    • ►  October (4)
    • ►  August (3)
    • ►  June (3)
    • ►  April (2)
    • ►  March (1)
    • ►  February (3)
    • ►  January (2)
  • ►  2008 (8)
    • ►  December (1)
    • ►  November (7)

Labels (Index)

  • "inferior" ST depression (5)
  • (Occlusion Myocardial Infarction) (5)
  • 3-Vessel disease (1)
  • Aberrant conduction (2)
  • Accelerated AV conduction (2)
  • accelerated idioventricular rhythm (6)
  • accelerated junctional rhythm (2)
  • Acidosis (1)
  • aconite (1)
  • acute right heart strain (2)
  • acuteness (6)
  • Adenosine (3)
  • Adjunctive Anti-Ischemic Therapy (2)
  • algorithm (5)
  • alkalosis (2)
  • alternating BBB (2)
  • Anomolous coronary artery (1)
  • anterior STEMI equation (11)
  • Anterior STEMI with minimal ST elevation less than 1 mm (10)
  • anterior T wave inversion (11)
  • Antiplatelet Therapy for UA/NonSTEMI (1)
  • Aortic Dissection (2)
  • Arrhythmogenic Right ventricular dysplasia (1)
  • artifact (2)
  • asthma (1)
  • Atrial enlargement and hypertrophy (1)
  • atrial flutter (19)
  • atrial repolarization wave (2)
  • Atrial Tachycardia (1)
  • atrial_fibrillation (8)
  • atrial_fibrillation with RVR (7)
  • Atypical Symptoms (1)
  • automatic rhythm (2)
  • AV block (10)
  • AV dissociation (10)
  • aVL (19)
  • AVNRT AV nodal re-entrant tachycardia (1)
  • aVR (16)
  • AVRT: AV Reciprocating Tachycardia (through accessory pathway) (2)
  • Benign T-wave Inversion (10)
  • Beta Adrenergic Blockade (4)
  • bidirectional tachycardia (1)
  • bradycardia (7)
  • BRASH (1)
  • brugada (7)
  • bundle branch block reentry ventricular tachycardia (1)
  • Cabrera's sign (4)
  • carbon monoxide poisoning (1)
  • cardiac arrest (29)
  • cardiac memory (1)
  • cardiogenic shock (7)
  • cardioversion (3)
  • Central Nervous System T-waves (1)
  • Chapman's sign (3)
  • Child (1)
  • Children (2)
  • circumflex occlusion (9)
  • CNS T-waves (1)
  • Co-culprit lesions (1)
  • Cocaine (1)
  • collateral circulation (2)
  • computer (13)
  • Concealed conduction in WPW and accessory pathways (2)
  • concordance (3)
  • concordant ST segments (2)
  • Convex ST Elevation (1)
  • coronary embolism (2)
  • CPR (1)
  • de Winter's T-waves (8)
  • Delayed Activation Wave (1)
  • demand ischemia (4)
  • Diagonal branch (D1 or D2) (4)
  • Diffuse ST Depression (6)
  • diffuse ST Elevation (2)
  • digitalis (4)
  • digoxin (3)
  • discordant (2)
  • Dr. K. Wang (20)
  • droperidol (1)
  • Drug Effect (2)
  • Dual AV nodal pathways (2)
  • Dynamic T-waves (9)
  • Early Repol Inferior and Lateral (1)
  • early repolarization (18)
  • Early Repolarization with Dynamic T-waves (2)
  • Echo-formal-false negative (1)
  • echocardiogram (16)
  • electrical alternans (2)
  • electrocardiographically silent (1)
  • Electrolytes (1)
  • Enhanced atrioventricular nodal conduction (EAVNC) (1)
  • Equation for Early Repol vs. Anterior STEMI (9)
  • ESRD (1)
  • evolving STEMI (6)
  • exaggerated STE (1)
  • excessively discordant ST depression (4)
  • Excessively discordant ST elevation (5)
  • false negative cath lab activation (2)
  • false positive cath lab activation (13)
  • False positive ECG (1)
  • False STEMI-NonSTEMI Dichotomy (1)
  • fascicular VT (6)
  • First Degree AV block (2)
  • flecainide (1)
  • Formula for Early Repol vs. Anterior STEMI (23)
  • fractional flow reserve (1)
  • fragmented QRS (5)
  • fusion beat (1)
  • half the QT (1)
  • HEART score (1)
  • Hemopericardium (1)
  • high lateral MI (8)
  • high lateral STEMI (7)
  • High Sensitivity Troponin (2)
  • hyperacute T-waves (37)
  • hyperacute T-waves V4-V6 (1)
  • hypercalcemia (3)
  • hyperkalemia (35)
  • hyperkalemia treatment (4)
  • hypertension (1)
  • Hypertrophic Cardiomyopathy (6)
  • hypocalcemia (5)
  • hypokalemia (19)
  • hypothermia (4)
  • idiopathic ventricular tachycardia (1)
  • Inferior Aneurysm Morphology (1)
  • Inferior de Winter's (1)
  • inferior early repolarization (2)
  • inferior hyperacute T-waves (11)
  • Inferior MI subtle (14)
  • inferior ST depression (11)
  • inferior STEMI (8)
  • inferoposterior STEMI (9)
  • intracranial hemorrhage (1)
  • intravascular ultrasound (1)
  • Intraventricular conduction delay (2)
  • Inverted U-wave (1)
  • Isolated Right Ventricular STEMI (1)
  • isorhythmic dissociation (6)
  • J-point (1)
  • J-waves (3)
  • junctional escape (4)
  • junctional tachycardia (1)
  • LAD occlusion (29)
  • LAD occlusion vs. benign early repolarization (32)
  • Ladder Diagram (3)
  • lateral STEMI (5)
  • LBBB (35)
  • lead misplacement (7)
  • Lead V1 (1)
  • left bundle branch block (15)
  • left main (12)
  • Lewis Lead (6)
  • literature (1)
  • long QT (14)
  • long ST segment (1)
  • low atrial rhythm (1)
  • Low Voltage (1)
  • Lown-Ganong-Levine (1)
  • LV aneurysm (24)
  • LV aneurysm lateral (1)
  • LVH (23)
  • McConnell’s Sign (1)
  • Mid anterolateral MI (2)
  • mirror image (1)
  • missed STEMI (17)
  • modified sgarbossa criteria (7)
  • mural thrombus (1)
  • myocardial contusion (3)
  • Myocardial Contusion - NOT! (2)
  • myocardial rupture (5)
  • Myocarditis (6)
  • narrow complex tachycardia (3)
  • Negative U-wave (1)
  • New LBBB (10)
  • New sign of LAD occlusion (1)
  • nitroglycerin (2)
  • No Reflow (1)
  • nondiagnostic ECG (1)
  • NonSTEMI (5)
  • normal angiogram in ACS (1)
  • normal ECG (4)
  • Normal ECG by computer algorithm (16)
  • Normal Intervals (1)
  • Normal Previous Angiogram (1)
  • normal variant ST Elevation (2)
  • NOT-pseudonormalization (2)
  • NSTEMI (5)
  • obtuse marginal (2)
  • Occlusion with less than 1mm ST Elevation (11)
  • OMI (20)
  • osborn waves (6)
  • P-wave morphology (1)
  • P-waves inverted (1)
  • paced rhythm (13)
  • pacing (7)
  • Papillary muscle (mitral valve) rupture (2)
  • PEA - Pulseless Electrical Activity (1)
  • Peaked T waves (4)
  • Pediatric (8)
  • Pericardial Tamponde (1)
  • pericarditis (16)
  • Persistent Juvenile T-waves (3)
  • persistent STE (4)
  • poisoning (1)
  • Polymorphic Ventricular Tachycardia (4)
  • posterior fascicular idiopathic VT (3)
  • posterior leads (9)
  • posterior reperfusion T-waves (7)
  • posterior STEMI (22)
  • postinfarction regional pericarditis (2)
  • PR interval (2)
  • Pre-excitation (1)
  • prehospital ECG (8)
  • Previous ECG (3)
  • progression of STEMI (2)
  • proportion (1)
  • pseudo RVMI (1)
  • Pseudoanteroseptal MI (2)
  • pseudoinfarction (23)
  • pseudonormalization (12)
  • Pseudonormalization of ST segments (2)
  • PseudoSTEMI (17)
  • pulmonary edema (4)
  • pulmonary embolism (11)
  • PVC (10)
  • q-waves (6)
  • QRS prolongation (1)
  • QRST angle (1)
  • QRST axis (1)
  • QS-waves (3)
  • QTc (4)
  • QTc rule of thumb (1)
  • R-on-T phenomenon (1)
  • RBBB (31)
  • RBBB with LAFB (Left Anterior Fascicular Block) (5)
  • re-occlusion (4)
  • reciprocal ST depression (12)
  • reciprocal T-wave inversion (1)
  • reocclusion (5)
  • Retrograde P-waves (1)
  • Reverse Takotsubo Stress Cardiomyopathy (1)
  • reversible T-wave inversion (2)
  • right bundle (6)
  • RIght Bundle Branch Block (1)
  • right sided leads (2)
  • Right Ventricular Hypertrophy (6)
  • Risks and risk factors for lytics/PCI (1)
  • RSR' (1)
  • RV Conduction Delay (1)
  • RV dysplasia (1)
  • RV MI (12)
  • RVH (8)
  • RVMI in lead V1 (7)
  • RVOT (right ventricular outflow tract ventricular tachycardia) (1)
  • saddleback STE (7)
  • Sasaki rule (1)
  • scooped ST depression (1)
  • Septal STEMI (5)
  • serial ECG (25)
  • serial EKG (8)
  • shark fin (1)
  • Shock (2)
  • short QT (5)
  • sick sinus (2)
  • signs of reperfusion (4)
  • Sine Wave (2)
  • sino-atrial exit block (2)
  • Sinus Pause/Sinus Arrest (1)
  • sinus tachycardia (3)
  • Sinus Tachycardia Extreme (2)
  • Sodium Channel Blockade (2)
  • Spasm (3)
  • Speckle Tracking Strain Echocardiography (2)
  • spontaneous coronary artery dissection (SCID) (1)
  • spontaneous reperfusion (8)
  • ST depression (32)
  • ST elevation (9)
  • ST resolution (1)
  • ST Segment Monitoring (3)
  • STE aVL (1)
  • STEMI (4)
  • STEMI vs. NonSTEMI (6)
  • STEMI with less than 1 mm ST elevation (9)
  • STEMI-equivalent (2)
  • Stenosis without thrombosis (1)
  • stokes-adams (1)
  • straight ST segments (1)
  • stress cardiomyopathy (9)
  • Stress Test (2)
  • stroke (1)
  • subacute MI (4)
  • subarachnoid hemorrhage (2)
  • subendocardial ischemia (7)
  • subtle (33)
  • Subtle Circumflex Occlusion (1)
  • Subtle Inferoposterior Occlusion (1)
  • Subtle LAD (10)
  • Subtle LAD Occlusion (21)
  • Subtle STE (13)
  • Superimposed: Acute on old MI (1)
  • Supraventricular Tachycardia (PSVT) (6)
  • SVT with aberrancy (7)
  • Synchronized Cardioversion (1)
  • Syncope (8)
  • T-Wave inversion (19)
  • tachycardia (2)
  • takotsubo (7)
  • TEE (transesophageal echo) (1)
  • terminal QRS distortion (8)
  • terminal T-wave inversion (1)
  • Third (3rd) degree AV block (5)
  • Thrombolytics (5)
  • Thrombus propagation (1)
  • Time Window for Reperfusion Therapy (1)
  • TIMI myocardial perfusion grading (1)
  • tombstones (1)
  • torsade (4)
  • Toxicology (2)
  • transient ST elevation (11)
  • transient T-wave inversion (1)
  • Triage ECG (2)
  • Triage Occlusion (1)
  • Tricyclic antidepressant (2)
  • troponin (5)
  • Type 2 Brugada (2)
  • type II MI (7)
  • Type II STEMI (2)
  • type III LAD (5)
  • Type_III_wraparound_LAD (5)
  • U-wave (1)
  • U-waves (15)
  • ultrasound (14)
  • unstable angina (16)
  • Up-Down T-waves (2)
  • upside down (1)
  • Valvular disorder (2)
  • Ventricular Fibrillation (7)
  • ventricular fibrillation on a 12 lead (2)
  • ventricular tachycardia (14)
  • Ventricular Tachycardia without structural cardiac abnormality (2)
  • verapamil (1)
  • wall motion abnormality (1)
  • wandering atrial pacemaker (1)
  • Wellens' classic evolution (1)
  • Wellens' in inferior or lateral leads ("reperfusion T-waves") (3)
  • Wellens' syndrome (22)
  • Wellens' Syndrome - NOT!! (4)
  • wenckebach (3)
  • wide complex (10)
  • Wide complex tachycardia (8)
  • wide QRS (6)
  • wide_complex_tachycardia (24)
  • Widespread ST Elevation (1)
  • wolff parkinson white WPW (14)
  • wraparound LAD (8)
  • Young Women (4)
Awesome Inc. theme. Powered by Blogger.